Validation pour Ingenuity257

vers la météo de la validation par utilisateur

Ingenuity257

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 60 - PMID ?

In liver from SP , IP of methyl clofenapate increases ( by 15 fold ) expression of SP NODE mRNA 30 hours after initial treatment .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

      +-----------------COMP:V-N(In)-----------------+----------------------------------COMP:V-N(after)---------------------------------+      
      +-------COMP:N-N(of)-------+                   |                         +-------COMP:N-N(of)-------+                             |      
      +--COMP:N-N(from)--+       |                   +---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                             |      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
COMP:N-N(from) (liver,IP)
COMP:N-N(of) (liver,methyl)
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 1

      +-----------------COMP:V-N(In)-----------------+----------------------------------COMP:V-N(after)---------------------------------+      
      +-------COMP:N-N(of)-------+                   |                         +-------COMP:N-N(of)-------+                             |      
      +--COMP:N-N(from)--+       |                   +---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                             |      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
COMP:N-N(from) (liver,IP)
COMP:N-N(of) (liver,methyl)
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 2

      +-----------------COMP:V-N(In)-----------------+                                                                                         
      +-------COMP:N-N(of)-------+                   |                         +-------COMP:N-N(of)-------+                                    
      +--COMP:N-N(from)--+       |                   +---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
COMP:N-N(from) (liver,IP)
COMP:N-N(of) (liver,methyl)
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 3

      +-----------------COMP:V-N(In)-----------------+                                                                                         
      +-------COMP:N-N(of)-------+                   |                         +-------COMP:N-N(of)-------+                                    
      +--COMP:N-N(from)--+       |                   +---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
COMP:N-N(from) (liver,IP)
COMP:N-N(of) (liver,methyl)
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 4

      +-----------------COMP:V-N(In)-----------------+                         +---------------------COMP:N-N(after)--------------------+      
      +-------COMP:N-N(of)-------+                   |                         +-------COMP:N-N(of)-------+                             |      
      +--COMP:N-N(from)--+       |                   +---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                             |      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
COMP:N-N(from) (liver,IP)
COMP:N-N(of) (liver,methyl)
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 5

      +-----------------COMP:V-N(In)-----------------+                         +---------------------COMP:N-N(after)--------------------+      
      +-------COMP:N-N(of)-------+                   |                         +-------COMP:N-N(of)-------+                             |      
      +--COMP:N-N(from)--+       |                   +---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                             |      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
COMP:N-N(from) (liver,IP)
COMP:N-N(of) (liver,methyl)
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 6

                                                     +----------------------------------COMP:V-N(after)---------------------------------+      
      +-----------------COMP:V-N(In)-----------------+                         +-------COMP:N-N(of)-------+                             |      
      +--COMP:N-N(from)--+       +----COMP:V-N(of)---+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                             |      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
COMP:N-N(from) (liver,IP)
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
COMP:V-N(of) (increase,methyl)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 7

                                                     +----------------------------------COMP:V-N(after)---------------------------------+      
      +-----------------COMP:V-N(In)-----------------+                         +-------COMP:N-N(of)-------+                             |      
      +--COMP:N-N(from)--+       +----COMP:V-N(of)---+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                             |      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
COMP:N-N(from) (liver,IP)
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
COMP:V-N(of) (increase,methyl)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 8

      +-----------------COMP:V-N(In)-----------------+----------------------------------COMP:V-N(after)---------------------------------+      
      |                  +-------COMP:V-N(from)------+                         +-------COMP:N-N(of)-------+                             |      
      |                  |       +----COMP:V-N(of)---+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                             |      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,IP)
COMP:V-N(of) (increase,methyl)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 9

      +-----------------COMP:V-N(In)-----------------+----------------------------------COMP:V-N(after)---------------------------------+      
      |                  +-------COMP:V-N(from)------+                         +-------COMP:N-N(of)-------+                             |      
      |                  |       +----COMP:V-N(of)---+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                             |      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,IP)
COMP:V-N(of) (increase,methyl)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 10

      +-----------------COMP:V-N(In)-----------------+                         +-------COMP:N-N(of)-------+                                    
      +--COMP:N-N(from)--+       +----COMP:V-N(of)---+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
COMP:N-N(from) (liver,IP)
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
COMP:V-N(of) (increase,methyl)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 11

      +-----------------COMP:V-N(In)-----------------+                         +-------COMP:N-N(of)-------+                                    
      +--COMP:N-N(from)--+       +----COMP:V-N(of)---+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
COMP:N-N(from) (liver,IP)
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
COMP:V-N(of) (increase,methyl)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 12

                                                                               +---------------------COMP:N-N(after)--------------------+      
      +-----------------COMP:V-N(In)-----------------+                         +-------COMP:N-N(of)-------+                             |      
      +--COMP:N-N(from)--+       +----COMP:V-N(of)---+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                             |      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
COMP:N-N(from) (liver,IP)
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
COMP:V-N(of) (increase,methyl)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 13

                                                                               +---------------------COMP:N-N(after)--------------------+      
      +-----------------COMP:V-N(In)-----------------+                         +-------COMP:N-N(of)-------+                             |      
      +--COMP:N-N(from)--+       +----COMP:V-N(of)---+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                             |      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
COMP:N-N(from) (liver,IP)
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
COMP:V-N(of) (increase,methyl)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 14

      +-----------------COMP:V-N(In)-----------------+                                                                                         
      |                  +-------COMP:V-N(from)------+                         +-------COMP:N-N(of)-------+                                    
      |                  |       +----COMP:V-N(of)---+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,IP)
COMP:V-N(of) (increase,methyl)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 15

      +-----------------COMP:V-N(In)-----------------+                                                                                         
      |                  +-------COMP:V-N(from)------+                         +-------COMP:N-N(of)-------+                                    
      |                  |       +----COMP:V-N(of)---+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,IP)
COMP:V-N(of) (increase,methyl)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 16

      +-----------------COMP:V-N(In)-----------------+                         +---------------------COMP:N-N(after)--------------------+      
      |                  +-------COMP:V-N(from)------+                         +-------COMP:N-N(of)-------+                             |      
      |                  |       +----COMP:V-N(of)---+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                             |      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,IP)
COMP:V-N(of) (increase,methyl)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 17

      +-----------------COMP:V-N(In)-----------------+                         +---------------------COMP:N-N(after)--------------------+      
      |                  +-------COMP:V-N(from)------+                         +-------COMP:N-N(of)-------+                             |      
      |                  |       +----COMP:V-N(of)---+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                             |      
      |           +MOD_AT+       |        +-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |           |      |       |        |          |           |             |           |       |      |   |   |     |      |        |      
 In liver from __SP__ , IP of methyl clofenapate increases ( by 15 fold ) expression of __SP__ __NODE__ mRNA 30 hours after initial treatment .
MOD_ATT:N-ADJ (IP,__SP__)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,IP)
COMP:V-N(of) (increase,methyl)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)